US 11,944,650 B2
Method of treating or preventing hernia formation
Frank Ho Pak Lau, New Orleans, LA (US); Ian Hodgdon, New Orleans, LA (US); and Michael Cook, New Orleans, LA (US)
Assigned to THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE, Baton Rouge, LA (US)
Filed by The Board of Supervisors of Louisiana State University and Agricultural and Mechanical College, Baton Rouge, LA (US)
Filed on Mar. 27, 2020, as Appl. No. 16/833,099.
Claims priority of provisional application 62/825,547, filed on Mar. 28, 2019.
Prior Publication US 2020/0330522 A1, Oct. 22, 2020
Int. Cl. A61K 35/50 (2015.01); A61B 17/00 (2006.01); A61F 2/00 (2006.01); A61K 9/00 (2006.01); A61L 27/24 (2006.01); A61L 27/36 (2006.01); A61L 31/00 (2006.01); A61L 31/16 (2006.01); A61P 41/00 (2006.01)
CPC A61K 35/50 (2013.01) [A61F 2/0063 (2013.01); A61K 9/0024 (2013.01); A61L 27/24 (2013.01); A61L 27/362 (2013.01); A61L 31/005 (2013.01); A61L 31/16 (2013.01); A61P 41/00 (2018.01); A61B 2017/00238 (2013.01); A61F 2002/0072 (2013.01); A61F 2220/0016 (2013.01); A61L 2430/34 (2013.01)] 14 Claims
 
1. A method of reducing the occurrence and/or development of a hernia within a subject at risk of developing a hernia, comprising:
implanting a graft material in contact with an opening in an abdominal fascia in an abdominal wall, wherein the graft material is not affixed to the abdominal fascia, wherein the graft material promotes healing of the abdominal wall opening and wherein the graft material consists essentially of unseparated amniotic membrane and chorionic membrane with an intact intermediate layer therein.